Flexion Therapeutics has named Scott Kelley, M.D., chief medical officer. Dr. Kelley previously served as the company’s vice president of Medical Affairs, and in his new role, he assumes responsibility for all medical matters at Flexion, including Medical Affairs, Clinical Research, and Clinical Operations.

“Scott’s promotion reflects his impressive capabilities and accomplishments, and we look forward to his continued success in his expanded role at this critical juncture in the company’s evolution.” said Michael Clayman, M.D., president and chief executive officer of Flexion. 

Prior to joining Flexion in May of 2016, Dr. Kelley served as vice president of Global Medical Affairs at Sanofi.